The Discounted Cash Flow (DCF) valuation of PTC Therapeutics Inc (PTCT) is 102.89 USD. With the latest stock price at 69.58 USD, the upside of PTC Therapeutics Inc based on DCF is 47.9%.
Based on the latest price of 69.58 USD and our DCF valuation, PTC Therapeutics Inc (PTCT) is a buy. buying PTCT stocks now will result in a potential gain of 47.9%.
| Range | Selected | |
| WACC / Discount Rate | 8.7% - 11.2% | 9.9% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 85.33 - 128.48 | 102.89 |
| Upside | 22.6% - 84.7% | 47.9% |